Seven patients had myopathy or myalgia (5.5%), five patients had rhabdomyolysis (3.9%), four patients (3.1%) experienced asymptomatic CPK elevation, and two patients (1.6%) had infusion site reactions without an elevated CPK. This evidence concerns the gene PIK3C2A and myopathy.